1987
DOI: 10.1016/0014-4827(87)90107-8
|View full text |Cite
|
Sign up to set email alerts
|

c-myc Oncogene expression inhibits the initiation of myogenic differentiation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
33
0
1

Year Published

1989
1989
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 60 publications
(35 citation statements)
references
References 28 publications
1
33
0
1
Order By: Relevance
“…An unanticipated finding in the present study was the induction of nAchR 6 gene expression in ras-transfected BC3H I and C2 cells after serum withdrawal, which is noteworthy in several respects. First, the presence of nAchR 6 mRNA indicates that activation of c-H-ras does not preclude the appearance of all muscle differentiation products, as might be inferred from previous results (12,18,19,62,63 43,64), and the possibility therefore exists that properties differing, for example, between'ras-and erbB-transfected cells are not inherent to these genes. However, although equivalency of dosage has not been yet established for v-erbB, the ras-transfected BC3H 1 cells contain only a single copy of the activated allele, under the control of its own promoter, and c-H-ras mRNA abundance is increased no more than threefold (18).…”
Section: S--mentioning
confidence: 81%
“…An unanticipated finding in the present study was the induction of nAchR 6 gene expression in ras-transfected BC3H I and C2 cells after serum withdrawal, which is noteworthy in several respects. First, the presence of nAchR 6 mRNA indicates that activation of c-H-ras does not preclude the appearance of all muscle differentiation products, as might be inferred from previous results (12,18,19,62,63 43,64), and the possibility therefore exists that properties differing, for example, between'ras-and erbB-transfected cells are not inherent to these genes. However, although equivalency of dosage has not been yet established for v-erbB, the ras-transfected BC3H 1 cells contain only a single copy of the activated allele, under the control of its own promoter, and c-H-ras mRNA abundance is increased no more than threefold (18).…”
Section: S--mentioning
confidence: 81%
“…We chose to analyse the c-myc gene, which is frequently translocated and/or ampli®ed in tumors (for review, see Marcu et al, 1992;Bishop, 1995), and the DHFR gene, whose genomic instability is altered following either drug selection (Stark, 1993), growth factor (Huang and Wright, 1994) or c-Myc overexpression (Denis et al, 1991;Mai, 1994;Mai et al, 1996). We also examined the CAD and the ribonucleotide reductase R1 (R1) genes.…”
Section: Abnormal Centrosome Ampli®cation In Vivo In P53mentioning
confidence: 99%
“…Moreover, c-Myc overexpression has been implicated in gene ampli®cation (Denis et al, 1991;Mai, 1994;Mai et al, 1996).…”
Section: Introductionmentioning
confidence: 99%
“…One possible interpretation of our findings is that N-myc expression may be required to expand specific pools of precursor cells by promoting their growth, inhibiting their death, and/or preventing their terminal differentiation. It has been shown that constitutive expression of c-myc can inhibit differentiation of cultured cell lines (Theile et al 1985;Coppola and Cole 1986;Denis et al 1987;Freytag 1988;Larcher et al 1991 ). In addition, it is notable that prelymphocytespecific growth factor, I1-7, induces N-myc in pre-B cells while also inducing proliferation, but not differentiation.…”
Section: Possible Function Of the N-myc Proteinmentioning
confidence: 99%